Kynam Capital Management, LP
CIK 1907884 · Holdings on Sep 30, 2024 · First reported Nov 14, 2024
Top ten holdings
Q3 2024- NTRA20.09%
- PCVX9.20%
- CLDX9.11%
- SNDX8.72%
- COGT7.73%
- DVAX7.19%
- VERA5.40%
- BCRX5.35%
- CGON5.18%
- VRDN4.43%
Share classes counted separately82.40%
Portfolio value by quarter
What changed this quarter?
Within preview · weight change- CGONWeight increased · +5.00 pp0.18% → 5.18%Shares +1.72M (+3184.68%)
- CLDXWeight decreased · -4.02 pp13.13% → 9.11%Shares +69.64K (+2.05%)
- SNDXWeight decreased · -3.58 pp12.30% → 8.72%Shares +120.87K (+2.11%)
Weight = security value ÷ total reported holdings value. Changes are in percentage points; price moves also affect weights, so they are not trade sizes.
Top 10 holdings 24
USD · B = billion · M = million; expand a row for exact values| # | Security | Value | Weight | Quantity | Weight / quantity change | Activity | |
|---|---|---|---|---|---|---|---|
| 01 | NTRANATERA INC View history and evidence | $259.29M | 20.09% | 2.04M shares | 22.84% → 20.09%-2.75 pp +28.06K (+1.39%) | Added | ↗▾ |
| 02 | PCVXVAXCYTE INC View history and evidence | $118.76M | 9.20% | 1.04M shares | 5.95% → 9.20%+3.25 pp +286.05K (+37.98%) | Added | ↗▾ |
| 03 | CLDXCELLDEX THERAPEUTICS INCCOM NEW View history and evidence | $117.56M | 9.11% | 3.46M shares | 13.13% → 9.11%-4.02 pp +69.64K (+2.05%) | Added | ↗▾ |
| 04 | SNDXSYNDAX PHARMACEUTICALS INC View history and evidence | $112.48M | 8.72% | 5.84M shares | 12.30% → 8.72%-3.58 pp +120.87K (+2.11%) | Added | ↗▾ |
| 05 | COGTCOGENT BIOSCIENCES INC View history and evidence | $99.79M | 7.73% | 9.24M shares | 8.17% → 7.73%-0.44 pp -20.65K (-0.22%) | Reduced | ↗▾ |
| 06 | DVAXDYNAVAX TECHNOLOGIES CORPCOM NEW View history and evidence | $92.83M | 7.19% | 8.33M shares | 8.33% → 7.19%-1.14 pp +1.25M (+17.65%) | Added | ↗▾ |
| 07 | VERAVERA THERAPEUTICS INCCL A View history and evidence | $69.68M | 5.40% | 1.58M shares | 5.85% → 5.40%-0.45 pp +32.88K (+2.13%) | Added | ↗▾ |
| 08 | BCRXBIOCRYST PHARMACEUTICALS INC View history and evidence | $69.05M | 5.35% | 9.09M shares | 5.71% → 5.35%-0.36 pp +258.66K (+2.93%) | Added | ↗▾ |
| 09 | CGONCG ONCOLOGY INC View history and evidence | $66.81M | 5.18% | 1.77M shares | 0.18% → 5.18%+5.00 pp +1.72M (+3184.68%) | Added | ↗▾ |
| 10 | VRDNVIRIDIAN THERAPEUTICS INC View history and evidence | $57.13M | 4.43% | 2.51M shares | 2.38% → 4.43%+2.05 pp +761.29K (+43.50%) | Added | ↗▾ |
Options overlay 1
$13.95M notionalPut and Call positions are separate. Notional is based on underlying securities, not option premium, market value or net exposure. Quantities are underlying shares.
| Security | Put / Call | Underlying shares | Notional | Quantity change | |
|---|---|---|---|---|---|
VRTXVERTEX PHARMACEUTICALS INC View history and evidence | Put | 30.00K | $13.95M | -300.00K (-90.91%) | ▾ |
1 / 1 options · preview only
Exited positions 3
| Security | Type | Shares out | Value out | Previous filing | This filing |
|---|---|---|---|---|---|
| SPY SS SPDR S&P 500 ETF TRUST-US | Put | -200,000 | -$109.10M | SEC filing ↗ | SEC filing ↗ |
| INSM INSMED INC | Call | -1,000,000 | -$67.00M | SEC filing ↗ | SEC filing ↗ |
| ALNY ALNYLAM PHARMACEUTICALS INC | Put | -43,000 | -$10.45M | SEC filing ↗ | SEC filing ↗ |
3 / 3 preview exits. Up to 30 exit records are previewed. Exit means absent from the current filing; execution date, price and proceeds are unknown.
Every number has a source.
CIK 1907884 · Period 2024-09-30
Data loaded 2026-09-23 · First reported 2024-11-14
Amendments and versions
{
"amendments_merged": null,
"prior_versions": null,
"cover_table_value": 1304499265
}Take these holdings further.
This page includes 25 of 25 reported holdings. Sign in to look up the full history beyond 3 years, use advanced screening & filtering, download CSV, and get the complete set through the Akkru API.
- Download CSV
- Earlier quarters
- Advanced screening & filtering
- API & AI access
＋ New accounts get free API credits to explore data beyond ownership filings.
For AI agents & developers
The initial HTML of this page carries its exact data as script#portfolio-data (JSON): values, units, scope, preview limits and SEC sources. Read it directly, no script or API key needed; script#research-access says what needs an account. This page lists 25 of 25 current positions (options included); totals and weights use the complete filing.
Without an account: the last 3 years, with the row caps stated on the page. A free account opens all history on file on these pages and the CSV of what a page shows. Rows beyond the caps and bulk retrieval go through the authenticated API / MCP.
MCP https://api.akkrudata.ai/mcp
get_institutional_portfolio
{"cik":"1907884","quarter":"2024Q3","page_size":100}
get_institutional_manager_history
{"cik":"1907884","page_size":100}Connect to MCP with OAuth and follow the returned pagination. Credits and usage limits depend on the account.
- MCP endpoint
- https://api.akkrudata.ai/mcp
- API / MCP documentation
- /documents
- llms.txt
- /llms.txt
Sources, coverage & how to read this data
Figures are as reported to the SEC and merged with later amendments where Akkru could match them. Preview limits apply to what is listed, not to the totals, which come from the complete reported data. Nothing is zero-filled: a missing quarter or month is shown as missing.